Maravai Lifesciences Holdings (MRVI) Dividends Paid - Common (2020 - 2024)
Maravai Lifesciences Holdings (MRVI) posted quarterly Dividends Paid - Common of -$78000.0 for Q4 2024, down 113.64% quarter-over-quarter from $572000.0 in Q2 2024.
Analysis
Maravai Lifesciences Holdings (MRVI) Dividends Paid - Common (2020 - 2024) Analysis & Trends
Maravai Lifesciences Holdings' Dividends Paid - Common history runs 5 years deep, the most recent figure standing at -$78000.0 for Q4 2024.
- In Q4 2024, Dividends Paid - Common changed N/A year-over-year to -$78000.0; the TTM figure through Sep 2025 stood at $494000.0 (down 13.64% YoY), while the FY2024 annual figure was $494000.0, down 94.86% from the prior year.
- Dividends Paid - Common for Q4 2024 stood at -$78000.0, down from $572000.0 in the prior quarter.
- The five-year high for Dividends Paid - Common was $119.7 million in Q4 2020, with the low at -$78000.0 in Q4 2024.
- The 5-year median for Dividends Paid - Common is $30.9 million (2022), against an average of $33.1 million.
- The sharpest annual moves came in 2021 and 2023: Dividends Paid - Common soared 40961.48% in 2021, then plunged 96.94% in 2023.
- Maravai Lifesciences Holdings' Dividends Paid - Common stood at $119.7 million in 2020, then declined by 8.1% to $110.0 million in 2021, then plunged by 71.89% to $30.9 million in 2022, then slumped by 95.78% to $1.3 million in 2023, then slumped by 105.98% to -$78000.0 in 2024.
- Business Quant data shows MRVI's Dividends Paid - Common at -$78000.0 in Q4 2024, $572000.0 in Q2 2024, and $1.3 million in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 96.80 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 34.60 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Maravai Lifesciences Holdings | 1.09 Bn | 1.02 Bn | 20.65 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -78,000.00 |
| Jun 30, 2024 | 572,000.00 |
| Jun 30, 2023 | 1.31 Mn |
| Mar 31, 2023 | 8.30 Mn |
| Dec 31, 2022 | 30.92 Mn |
| Sep 30, 2022 | 36.81 Mn |
| Jun 30, 2022 | 42.59 Mn |
| Mar 31, 2022 | 39.89 Mn |
| Dec 31, 2021 | 110.00 Mn |
| Sep 30, 2021 | 50.10 Mn |
| Jun 30, 2021 | 33.08 Mn |
| Mar 31, 2021 | 23.13 Mn |
| Dec 31, 2020 | 119.69 Mn |
| Sep 30, 2020 | 122,000.00 |
| Jun 30, 2020 | 190,000.00 |